DrugEYE™, Data-driven drug discovery
Customer needs and expectations are changing rapidly, and traditional multi-criteria segmentation or clustering methods are no longer sufficient to act on the rapidly changing customer needs. The solutions allows to anticipate on customer needs based on a robust modelling of their behaviour and preferences, giving your company a leap ahead of the competition.
- AI inferred customer segmentation
- Automatic update of the segmentation identifying emerging customer behavioural patterns
- Ongoing recommendation engine for up-selling, cross-selling, Next Best Opportunities, Next Best Actions, best channel
Related news
MajestEYE winner of the "Best Artificial Intelligence solution in e-health" competition Jihed Hannachi - Co-Founder of MajestEYE receiving the award on behalf of MajestEYE In recent weeks, the spread of…
Digital Transformation is an umbrella term for how businesses adapt their business models to accommodate new technologies like Artificial Intelligence (AI) and big data analytics, enabling them to understand their…
MajestEYE was selected by JICA, the Japanese International Cooperation Agency, among the top 10 most innovative start-ups in Africa for its Artificial Intelligence solution DrugEYE™, which sets to disrupt the…
Using data analytics to provide businesses with more insights We’re witnessing a rise in the use of big data for analysis across all industries – from healthcare to commerce –…
